Development of Antibodies with Broad Neutralization Specificities against HIV-1 after Long Term SHIV Infection in Macaques

被引:5
作者
Gao, Nan [1 ]
Gai, Yanxin [1 ]
Meng, Lina [1 ]
Wang, Chu [1 ]
Zhang, Xin [1 ]
Wang, Wei [2 ,3 ]
Qin, Chuan [2 ,3 ]
Yu, Xianghui [1 ,4 ]
Gao, Feng [1 ,5 ]
机构
[1] Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130012, Peoples R China
[2] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100021, Peoples R China
[3] Peking Union Med Coll, Comparat Med Ctr, Beijing 100021, Peoples R China
[4] Jilin Univ, Sch Life Sci, Key Lab Mol Enzymol & Engn, Minist Educ, Changchun 130012, Peoples R China
[5] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
来源
VIRUSES-BASEL | 2020年 / 12卷 / 02期
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
simian; human immunodeficiency virus; neutralizing antibody; specificities; non-human primate; escape mutation; MONOCLONAL-ANTIBODIES; DEPENDENT EPITOPE; RHESUS MACAQUES; POTENT; RESPONSES; IDENTIFICATION; LINEAGES;
D O I
10.3390/v12020163
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Non-human primates (NHP) are the only animal model suitable to evaluate the protection efficacy of HIV-1 vaccines. It is important to understand how and when neutralizing antibodies (nAbs) with specificities similar to those of human broadly neutralizing antibodies (bnAbs) develop in NHPs. To address these questions, we determined plasma neutralization specificities in two macaques which developed neutralization breadth after long-term simian/human immunodeficiency virus (SHIV) infection and identified neutralization escape mutations by analyzing the env sequences from longitudinal plasma samples. Neutralization activities targeting V2, CD4bs, V3 and gp120-gp41 interface only became detectable in week 350 plasma from macaques G1015R and G1020R using 25710 env mutants. When mapped with CAP45 env mutants, only V2 specificity was detected at week 217 and persisted until week 350 in G1015R. Neutralization escape mutations were found in CD4bs and V2 regions. However, all of them were different from those resistant mutations identified for human bnAbs. These results show that nAbs with specificities similar to human bnAbs are only detectable after long-term SHIV infection and that neutralization escape mutations in macaques are different from those found in HIV-1-infected individuals. These findings can have important implications in the best utilization of the NHP model to evaluate HIV-1 vaccines.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Immunologic basis for long HCDR3s in broadly neutralizing antibodies against HIV-1
    Yu, Lei
    Guan, Yongjun
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [42] Broadly neutralizing plasma antibodies effective against autologous circulating viruses in infants with multivariant HIV-1 infection
    Mishra, Nitesh
    Sharma, Shaifali
    Dobhal, Ayushman
    Kumar, Sanjeev
    Chawla, Himanshi
    Singh, Ravinder
    Makhdoomi, Muzamil Ashraf
    Das, Bimal Kumar
    Lodha, Rakesh
    Kabra, Sushil Kumar
    Luthra, Kalpana
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [43] Prime-boost regimens with adjuvanted synthetic long peptides elicit T cells and antibodies to conserved regions of HIV-1 in macaques
    Rosario, Maximillian
    Borthwick, Nicola
    Stewart-Jones, Guillaume B.
    Mbewe-Mvula, Alice
    Bridgeman, Anne
    Colloca, Stefano
    Montefiori, David
    McMichael, Andrew J.
    Nicosia, Alfredo
    Quakkelaar, Esther D.
    Drijfhout, Jan W.
    Melief, Cornelis J. M.
    Hanke, Tomas
    AIDS, 2012, 26 (03) : 275 - 284
  • [44] Vaccine-Induced, High-Magnitude HIV Env-Specific Antibodies with Fc-Mediated Effector Functions Are Insufficient to Protect Infant Rhesus Macaques against Oral SHIV Infection
    Curtis, Alan D., II
    Saha, Pooja T.
    Dennis, Maria
    Berendam, Stella J.
    Ramasubramanian, Pratamesh
    Cross, Kaitlyn A.
    Alam, S. Munir
    Ferrari, Guido
    Kozlowski, Pamela A.
    Fouda, Genevieve G.
    Hudgens, Michael G.
    Van Rompay, Koen K. A.
    Pollara, Justin
    Permar, Sallie R.
    De Paris, Kristina
    MSPHERE, 2022, 7 (01)
  • [45] Long-term inhibition of HIV-1 replication with RNA interference against cellular co-factors
    Eekels, Julia J. M.
    Geerts, Dirk
    Jeeninga, Rienk E.
    Berkhout, Ben
    ANTIVIRAL RESEARCH, 2011, 89 (01) : 43 - 53
  • [46] Neuropathogenesis of HIV-1: insights from across the spectrum of acute through long-term treated infection
    Killingsworth, Lauren
    Spudich, Serena
    SEMINARS IN IMMUNOPATHOLOGY, 2022, 44 (05) : 709 - 724
  • [47] Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera
    Hao, Yuxia
    Bai, Ge
    Wang, Junping
    Zhao, Longfeng
    Sutherland, Kyle
    Cai, Jianfeng
    Cao, Chuanhai
    BMC IMMUNOLOGY, 2015, 16
  • [48] Astrocytes sustain long-term productive HIV-1 infection without establishment of reactivable viral latency
    Barat, Corinne
    Proust, Alize
    Deshiere, Alexandre
    Leboeuf, Mathieu
    Drouin, Jean
    Tremblay, Michel J.
    GLIA, 2018, 66 (07) : 1363 - 1381
  • [49] Mapping of Neutralizing Antibody Epitopes on the Envelope of Viruses Obtained from Plasma Samples Exhibiting Broad Cross-Clade Neutralization Potential Against HIV-1
    Cheedarla, Narayanaiah
    Sundaramurthi, Jagadish Chandrabose
    Hemalatha, Babu
    Anangi, Brahmaiah
    Nesakumar, Manohar
    Ashokkumar, Manickam
    Vijayan, K. K. Vidya
    Tripathy, Srikanth Prasad
    Swaminathan, Soumya
    Vaniambadi, S. Kalyanaraman
    Ramanathan, D. Vadakkupattu
    Hanna, Luke Elizabeth
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2019, 35 (02) : 169 - 184
  • [50] Partial Recovery of Telomere Length After Long-term Virologic Suppression in Persons With HIV-1
    Cadinanos, Julen
    Rodriguez-Centeno, Javier
    Montejano, Rocio
    Esteban-Cantos, Andres
    Mena-Garay, Beatriz
    Jimenez-Gonzalez, Maria
    Saiz-Medrano, Gabriel
    de Miguel, Rosa
    Rodriguez-Artalejo, Fernando
    Bernardino, Jose, I
    Marcelo-Calvo, Cristina
    Gutierrez-Garcia, Lucia
    Martinez-Martin, Patricia
    Diez Vidal, Alejandro
    de Gea Grela, Alejandro
    Ortola, Rosario
    Rodes, Berta
    Arribas, Jose R.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (10):